These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26854643)

  • 21. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
    Ducki S; Rennison D; Woo M; Kendall A; Chabert JF; McGown AT; Lawrence NJ
    Bioorg Med Chem; 2009 Nov; 17(22):7698-710. PubMed ID: 19837593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of benzo[d]imidazo[2,1-b]thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents.
    Sultana F; Reddy Bonam S; Reddy VG; Nayak VL; Akunuri R; Rani Routhu S; Alarifi A; Halmuthur MSK; Kamal A
    Bioorg Chem; 2018 Feb; 76():1-12. PubMed ID: 29102724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles.
    Yadav P; Lal K; Kumar A; Guru SK; Jaglan S; Bhushan S
    Eur J Med Chem; 2017 Jan; 126():944-953. PubMed ID: 28011424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
    Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
    Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents.
    Kamal A; Shaik AB; Jain N; Kishor C; Nagabhushana A; Supriya B; Bharath Kumar G; Chourasiya SS; Suresh Y; Mishra RK; Addlagatta A
    Eur J Med Chem; 2015 Mar; 92():501-13. PubMed ID: 25599948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.
    Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of novel chalcone derivatives as a new class of microtubule destabilizing agents.
    Huang X; Huang R; Li L; Gou S; Wang H
    Eur J Med Chem; 2017 May; 132():11-25. PubMed ID: 28340411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Biological Evaluation of 1-Methyl-1H-indole-Pyrazoline Hybrids as Potential Tubulin Polymerization Inhibitors.
    Zhang YL; Qin YJ; Tang DJ; Yang MR; Li BY; Wang YT; Cai HY; Wang BZ; Zhu HL
    ChemMedChem; 2016 Jul; 11(13):1446-58. PubMed ID: 27159418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, cytotoxic properties and tubulin polymerization inhibitory activity of novel 2-pyrazoline derivatives.
    Abdel-Aziz M; Aly OM; Khan SS; Mukherjee K; Bane S
    Arch Pharm (Weinheim); 2012 Jul; 345(7):535-48. PubMed ID: 22592968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
    Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
    Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, Anticancer Activity and Molecular Modeling Studies of Novel Chalcone Derivatives Containing Indole and Naphthalene Moieties as Tubulin Polymerization Inhibitors.
    Wang G; Peng Z; Li Y
    Chem Pharm Bull (Tokyo); 2019 Jul; 67(7):725-728. PubMed ID: 30982797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
    Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
    Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological studies of novel tubulin inhibitors.
    Sun Y; Pandit B; Chettiar SN; Etter JP; Lewis A; Johnsamuel J; Li PK
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4465-8. PubMed ID: 23790539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.
    Romagnoli R; Baraldi PG; Cruz-Lopez O; Lopez Cara C; Carrion MD; Brancale A; Hamel E; Chen L; Bortolozzi R; Basso G; Viola G
    J Med Chem; 2010 May; 53(10):4248-58. PubMed ID: 20420439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors.
    Ouyang X; Chen X; Piatnitski EL; Kiselyov AS; He HY; Mao Y; Pattaropong V; Yu Y; Kim KH; Kincaid J; Smith L; Wong WC; Lee SP; Milligan DL; Malikzay A; Fleming J; Gerlak J; Deevi D; Doody JF; Chiang HH; Patel SN; Wang Y; Rolser RL; Kussie P; Labelle M; Tuma MC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5154-9. PubMed ID: 16198562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent combretastatin A-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study.
    Mustafa M; Anwar S; Elgamal F; Ahmed ER; Aly OM
    Eur J Med Chem; 2019 Dec; 183():111697. PubMed ID: 31536891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
    Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B
    Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.
    Duan YT; Man RJ; Tang DJ; Yao YF; Tao XX; Yu C; Liang XY; Makawana JA; Zou MJ; Wang ZC; Zhu HL
    Sci Rep; 2016 May; 6():25387. PubMed ID: 27138035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of (1-aryl-1H-pyrazol-4-yl) (3,4,5-trimethoxyphenyl)methanone derivatives as tubulin inhibitors.
    Zhai M; Wang L; Liu S; Wang L; Yan P; Wang J; Zhang J; Guo H; Guan Q; Bao K; Wu Y; Zhang W
    Eur J Med Chem; 2018 Aug; 156():137-147. PubMed ID: 30006160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of New N
    Elmeligie S; Khalil NA; Ahmed EM; Emam SH; Zaitone SA
    Biol Pharm Bull; 2016; 39(10):1611-1622. PubMed ID: 27725438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.